Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
03/31/2025 | Q1 | $45.6M | -- | -- | -$0.04 | -- |
02/28/2025 | Q4 | $43M | -- | -- | -$0.03 | -- |
10/30/2024 | Q3 | $41M | $45M | -$0.07 | -$0.08 | $0.00 |
07/31/2024 | Q2 | $48.2M | $37.2M | -$0.12 | -$0.07 | -$0.05 |
05/08/2024 | Q1 | $46M | $45.5M | -$0.27 | -$0.10 | -$0.17 |
02/28/2024 | Q4 | $24.9M | $28.2M | -$0.25 | -$0.13 | -$0.12 |
11/07/2023 | Q3 | -- | -- | -$0.27 | -$0.12 | -$0.15 |
08/08/2023 | Q2 | -- | -- | -$0.22 | -$0.10 | -$0.12 |
05/09/2023 | Q1 | -- | -- | -$0.21 | -- | -- |
02/14/2023 | Q4 | -- | -- | -$0.26 | -- | -- |
11/08/2022 | Q3 | -- | -- | -$0.37 | -- | -- |
08/08/2022 | Q2 | -- | -- | -$0.82 | -- | -- |
05/05/2022 | Q1 | -- | -- | -$0.99 | -- | -- |
02/17/2022 | Q4 | -- | -- | -$0.12 | -- | -- |
09/30/2021 | Q3 | -- | -- | -$0.18 | -- | -- |
06/30/2021 | Q2 | -- | -- | -$0.23 | -- | -- |
03/31/2021 | Q1 | -- | -- | -$0.25 | -- | -- |
12/31/2020 | Q4 | -- | -- | -$0.24 | -- | -- |
09/30/2020 | Q3 | -- | -- | -$0.08 | -- | -- |
06/30/2020 | Q2 | -- | -- | -$0.18 | -- | -- |
03/31/2020 | Q1 | -- | -- | -$0.23 | -- | -- |
12/31/2019 | Q4 | -- | -- | -$0.18 | -- | -- |
09/30/2019 | Q3 | -- | -- | -$0.19 | -- | -- |
06/30/2019 | Q2 | -- | -- | -$0.20 | -- | -- |
03/31/2019 | Q1 | -- | -- | -$0.44 | -- | -- |
12/31/2018 | Q4 | -- | -- | -$0.36 | -- | -- |
09/30/2018 | Q3 | -- | -- | -$0.38 | -- | -- |
06/30/2018 | Q2 | -- | -- | -$0.42 | -- | -- |
03/31/2018 | Q1 | -- | -- | -$0.34 | -- | -- |
12/31/2017 | Q4 | -- | -- | -$0.27 | -- | -- |
09/30/2017 | Q3 | -- | -- | -$0.46 | -- | -- |
06/30/2017 | Q2 | -- | -- | -$0.58 | -- | -- |
03/31/2017 | Q1 | -- | -- | -$0.59 | -- | -- |
12/31/2016 | Q4 | -- | -- | -$0.61 | -- | -- |
09/30/2016 | Q3 | -- | -- | -$0.68 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$0.64 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.69 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.45 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$0.32 | -- | -- |
06/30/2015 | Q2 | -- | -- | -$0.53 | -- | -- |
03/31/2015 | Q1 | -- | -- | -$0.56 | -- | -- |
Standard BioTools reported $45M worth of top line sales in its most recent quarter.
Standard BioTools announced earnings per share of -$0.07 which represents a beat of analyst forecast a -$0.08 per share.
Standard BioTools reported $23.3M that represents $0.06 per share over the last quarter.
Standard BioTools's earnings are forecast to decrease from -$0.94 per share to -$0.22 per share next year representing a decrease of -77.13%.
Standard BioTools's next earnings date is February 28, 2025.
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.